A DNA-Launched Nanoparticle Vaccine Elicits CD8+ T-cell Immunity to Promote In Vivo Tumor Control.
Cancer Immunol Res
; 8(11): 1354-1364, 2020 11.
Article
in En
| MEDLINE
| ID: mdl-32913042
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
T-Lymphocytes
/
CD8-Positive T-Lymphocytes
/
Vaccines, DNA
/
Nanoparticles
/
Neoplasms
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Cancer Immunol Res
Year:
2020
Type:
Article